Myelin VC

Details

Stages

Pre-seed Seed Series A Series B Pre-IPO

Check size

250K - 1M

Operating countries

ARGENTINA](/content/en/investors/ar/index.html)
BRAZIL](/content/en/investors/br/index.html)
CHILE](/content/en/investors/cl/index.html)
COLOMBIA](/content/en/investors/co/index.html)
MEXICO](/content/en/investors/mx/index.html)
GERMANY](/content/en/investors/de/index.html)
BELGIUM](/content/en/investors/be/index.html)
FINLAND](/content/en/investors/fi/index.html)
FRANCE](/content/en/investors/fr/index.html)
ITALY](/content/en/investors/it/index.html)
NORWAY](/content/en/investors/no/index.html)
RUSSIAN FEDERATION](/content/en/investors/ru/index.html)
UNITED STATES](/content/en/investors/us/index.html)
SPAIN](/content/en/investors/es/index.html)
UNITED KINGDOM](/content/en/investors/gb/index.html)

About us

Myelin is a venture capital firm based in San Francisco, California. It was founded in 2017 with the mission to “invest in and build software companies that will make the world a better place.” Myelin focuses on early-stage technology investments in areas such as artificial intelligence, machine learning, healthcare, financial services, and consumer applications. The firm has invested in over 30 companies, including Truepill, Wise Systems, and Oscar Health. Myelin also offers a number of support services to its portfolio companies, including strategic advice and mentorship, recruiting and talent acquisition, and access to its network of investors and entrepreneurs.

Firm type

Venture Capital

Sectors we like

ARTIFICIAL INTELLIGENCE AGNOSTIC XR AR

Similar investors

Decade Ventures](/content/en/investor/decade-ventures/index.html)

First Stage Labs](/content/en/investor/first-stage-labs/index.html)

Cloud Capital](/content/en/investor/cloud-capital/index.html)

Navus Ventures](/content/en/investor/navus-ventures/index.html)

Samsung Catalyst Fund](/content/en/investor/samsung-catalyst-fund/index.html)